by: Parent Project Muscular DystrophyWhat is CRISPR/Cas9? (July 2016)
You’ve seen the headlines and heard the name, now find out more about CRISPR/Cas9 and what this technology could mean for Duchenne. On July 13, 2016 PPMD was joined by Dr. Eric Olson from the Department of Molecular Biology at UT Southwestern Medical Center to discuss the basics of gene editing and the potential permanent correction of Duchenne mutations with CRISPR/Cas9.
